Transcatheter aortic valve replacement pioneer Martin Leon discussed what is coming down the pike for technologies in the TAVR and heart valve device space at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. Here is a run-down of what he highlighted, including AI-driven technologies that promise to improve patient access and outcomes. This is the first of a two-part series focusing on innovations in interventional cardiology.
The first transcatheter aortic valve replacement (TAVR) was performed 16 years ago and it is now a well-entrenched part of cardiac care worldwide. Interventional cardiologist Martin Leon, one of the pioneers of TAVR, says people think that innovation TAVR has reached its saturation point, but he is not one of them.
"I don't believe that," Leon told a jam-packed room at this year's Transcatheter Cardiovascular Therapeutics conference in San Diego last month